GlassScriptPhysician profile
Betsy S August
NPI 1346231271
$3,165.44
in general payments reported to CMS, 2019-2025
12 companies · $28.01 in 2025
The $28.01 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $94.01 · 2021: $650 · 2022: $61.79 · 2023: $1,575 · 2024: $27.01 · 2025: $28.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,575 · Food and Beverage: $55.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,575.00 |
| Food and Beverage | $55.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,602.01 | 2023-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Medtronic, INC. | $650.00 | 2021 | |
| Abbvie INC. | $508.44 | 2019 | |
| Avion Pharmaceuticals | $107.39 | 2019-2020 | |
| Coopersurgical, INC. | $73.76 | 2019-2020 | |
| Organon LLC | $49.76 | 2022 | |
| Astellas Pharma US INC | $41.19 | 2019-2025 | Veozah |
| Pfizer INC. | $38.46 | 2019-2022 | |
| Allergan, INC. | $36.29 | 2019 | |
| Therapeuticsmd, INC. | $30.45 | 2019 | |
| Merck Sharp & Dohme LLC | $15.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy August listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.